Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS therapy Evaluation in the Netherlands (ATHENA) cohort

Clinical Infectious Diseases

Volumn 50, Issue 2, 2010, Pages 255-263

  De Boer van Der Kolk, I Marion ^a   Sprangers, Mirjam A G ^a   Prins, Jan M ^b   Smit, Colette ^c   De Wolf, Frank ^c   Nieuwkerk, Pythia T ^a  

^a Department of Medical Psychology ^*  (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STICHTING HIV MONITORING   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEALTH; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; NETHERLANDS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SURVIVAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 73649103143     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649216     Document Type: Article

References (25)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Dept of Health and Human Services, 2008.
3. Idler E, Kasl S. Self-ratings of health: do they also predict change in functional ability? J Gerontol B Psychol Sci Soc Sd 1995; 50:S344-S353.
4. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008;26:1355-1363.
5. Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64: 339-349.
6. 6. Cunningham W, Crystal S, Bozzette S, Hays R. The association of health-related quality of life with survival among persons with HIV infections in the United States. J Gen Intern Med 2005;20:21-27. (Pubitemid 40271034)
7. Jacobson D, Wu A, Feinberg J, for the Outcomes Committee of the Adult AIDS Clinical Trials Group. Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. J Clin Epidemiol 2003; 56: 874-879.
8. 8. Mathews WC, May S. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes 2007;5:5-9. (Pubitemid 46306387)
9. van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003;17:2227-11236
10. Gras L, Sighem AV, Smit C, et al. Monitoring of human immunodeficiency virus (HIV) infection in the Netherlands Report 2007. Amsterdam, the Netherlands: HIV Monitoring Foundation, 2008.
11. 11. Revicki DA, Sorensen S, Wu AW Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998;36:126-137. (Pubitemid 128454304)
12. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 1991; 29:786-798.
13. 13. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997;6:481-493. (Pubitemid 27431704)
14. Copenhagen HIV Programme. Coding Causes of Death in HIV. 2005. Available at: http://www.cphiv.dk/CoDe/About/tabid/64/Default.aspx. Accessed 4 January 2009.
15. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41 (RR17):1-19.
16. 16. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/ AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr 2007; 46:323-327. (Pubitemid 350287360)
17. Mannheimer SB, Wold N, Gardner EM, et al. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis 2008;46:941-945.
18. 18. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-830. (Pubitemid 30256376)
19. 19. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007; 21: 1175-1183. (Pubitemid 46763288)
20. 20. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDSrelated mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004;94:1133-1140. (Pubitemid 38857313)
21. 21. Villes V, Spire B, Lewden C, et al. The effect of depressive symptoms at ART initiation on HlV clinical progression and mortality: implications in clinical practice. Antivir Ther 2007;12:1067-1074. (Pubitemid 350114987)
22. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-1474.
23. 23. Fleishman JA, Crystal S. Functional status transitions and survival in HIV disease: evidence from the AIDS Costs and Service Utilization Survey. Med Care 1998;36:533-543. (Pubitemid 128452880)
24. Mackenbach JP, Simon JG, Looman CW, Joung IM. Self-assessed health and mortality: could psychosocial factors explain the association? Int J Epidemiol 2002;31:1162-1168.
25. Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA; The Prometheus Study Group. Quality of life in asymptomatic and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS 2000;14:181-187.